CRO Kendle has named Martha R. Feller, Ph.D., vice president and global head of study start-up. Dr. Feller brings to Kendle more than 30 years of senior operations leadership in the clinical development industry, including therapeutic expertise and experience in managing global development programs. She will provide leadership for Kendle's global study start-up function, including management, site identification, regulatory, investigator contracts and essential document collection.
Dr. Feller rejoins Kendle following two years with i3 Research where she served as executive vice president, global operations, responsible for phase I-III clinical programs. Previously, she was senior vice president, global clinical development at Kendle. Before joining Kendle, she spent 24 years with Procter & Gamble Pharmaceuticals.